• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝表面抗原作为HIV感染患者循环免疫复合物中的抗原成分。

HBsAg as the antigen component of circulating immune complexes in HIV-infected patients.

作者信息

Stanojevic M, Zerjav S, Jevtovic D J, Markovic L J

机构信息

Institute for Infectious and Tropical Diseases CCS, University of Belgrade, Yugoslavia.

出版信息

Biomed Pharmacother. 2000 Apr;54(3):163-7. doi: 10.1016/S0753-3322(00)89049-6.

DOI:10.1016/S0753-3322(00)89049-6
PMID:10840593
Abstract

Seeing the same transmission pattern of HIV and HBV coinfection by these two agents is not an uncommon feature. Immunity impairment due to HIV infection can be the cause of a higher rate of HBV replication with less intensive liver damage and less effective immune response to HBV, while the pathological course in both infections involves elevated levels of circulating immune complexes (CIC). These were the reasons for us to examine the frequency of HBsAg involvement as the antigen component of circulating immune complexes formed in sera of HIV-infected patients in different stages of HIV disease. We tested 67 sera of HIV-positive patients in different stages of HIV disease for the presence of HBsAg and HIV antigen p24 (with and without acid dissociation of immune complexes), for the presence of anti-Hbc antibodies and circulating immune complexes. HBsAg was positive in 13.8% sera prior to and 33.8% after acid pretreatment. Anti-HBc antibodies were present in 76.9% serum samples tested. Fifty percent of sera were positive for both HBsAg and p24 antigen after dissociation of immune complexes. The level of CIC was elevated in 65.9% of sera. Our results suggest that HBsAg is commonly associated in immune complexes formed in the sera of HIV-infected patients and that they may simultaneously contain HIV and HBsAg in patients coinfected with both agents. This may contribute to their mutual interaction and influence the diagnosis and follow-up of patients.

摘要

这两种病原体导致的HIV和HBV合并感染呈现相同的传播模式并非罕见特征。HIV感染所致的免疫损伤可能是HBV复制率较高、肝损伤较轻且对HBV免疫反应较弱的原因,而两种感染的病理过程均涉及循环免疫复合物(CIC)水平升高。这些就是我们研究在HIV疾病不同阶段的HIV感染患者血清中形成的循环免疫复合物的抗原成分中HBsAg参与频率的原因。我们检测了67份处于HIV疾病不同阶段的HIV阳性患者血清,以检测HBsAg和HIV抗原p24的存在情况(免疫复合物有无酸解离)、抗-Hbc抗体和循环免疫复合物的存在情况。酸预处理前13.8%的血清中HBsAg呈阳性,酸预处理后为33.8%。检测的血清样本中有76.9%存在抗-HBc抗体。免疫复合物解离后,50%的血清中HBsAg和p24抗原均呈阳性。65.9%的血清中CIC水平升高。我们的结果表明,HBsAg通常与HIV感染患者血清中形成的免疫复合物相关,并且在这两种病原体合并感染的患者中,免疫复合物可能同时含有HIV和HBsAg。这可能有助于它们之间的相互作用,并影响患者的诊断和随访。

相似文献

1
HBsAg as the antigen component of circulating immune complexes in HIV-infected patients.乙肝表面抗原作为HIV感染患者循环免疫复合物中的抗原成分。
Biomed Pharmacother. 2000 Apr;54(3):163-7. doi: 10.1016/S0753-3322(00)89049-6.
2
[Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection].[乙型肝炎病毒感染患者血清中含乙肝表面抗原的循环免疫复合物(CIC HBsAG/IgM和CIC HBsAG/IgG)抗原特异性测定的免疫酶分析]
Biull Eksp Biol Med. 1992 Feb;113(2):174-6.
3
Antigen/antibody content of circulating immune complexes in HIV-infected patients.HIV感染患者循环免疫复合物中的抗原/抗体含量。
Biomed Pharmacother. 1996;50(10):488-93. doi: 10.1016/s0753-3322(97)89279-7.
4
Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.通过性传播感染艾滋病毒患者中隐匿性乙型和丙型肝炎的患病率。
Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.
5
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的HIV感染患者乙肝血清学标志物的演变
Clin Infect Dis. 2007 Nov 1;45(9):1221-9. doi: 10.1086/522173. Epub 2007 Sep 21.
6
[Course control and significance of circulating HBsAg-specific immune complexes in acute viral hepatitis B].[急性乙型病毒性肝炎循环中HBsAg特异性免疫复合物的病程控制及意义]
Dtsch Z Verdau Stoffwechselkr. 1986;46(4):229-42.
7
Diagnosis and management of hepatitis B virus and HIV coinfection.乙型肝炎病毒与艾滋病毒合并感染的诊断和管理
Top HIV Med. 2007 Nov-Dec;15(5):163-6.
8
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.HIV感染者隐匿性乙型肝炎病毒感染的预测因素及动力学
J Med Virol. 2007 Oct;79(10):1464-71. doi: 10.1002/jmv.20954.
9
Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.乙肝核心抗原单独抗体检测呈阳性的HIV-1阳性受试者对乙肝疫苗的反应:对乙肝疫苗策略的影响
J Infect Dis. 2005 May 1;191(9):1435-41. doi: 10.1086/429302. Epub 2005 Mar 28.
10
Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.通过用标记的乙肝病毒核心抗原进行免疫沉淀法,对持续性乙肝感染患者的抗-HBc无反应血清样本进行重新评估。
J Clin Virol. 2009 Oct;46(2):124-8. doi: 10.1016/j.jcv.2009.06.018. Epub 2009 Jul 24.

引用本文的文献

1
Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection.循环免疫复合物和乙肝表面抗原(HBsAg)突变与抗-HBs和HBeAg阳性隐匿性乙型肝炎病毒感染中无法检测到的HBsAg有关。
Front Microbiol. 2022 Nov 29;13:1063616. doi: 10.3389/fmicb.2022.1063616. eCollection 2022.